Exploring Autologous CD-19 CAR-Tregs for Rheumatology to Advance Treatment Development for Unmet Diseases
Time: 1:10 pm
day: Conference Day One Pink Track P2
Details:
- Explore the role of the immune system in rheumatoid scleroderma
- Hear preclinical evidence from Quell Therapeutics on their novel therapy targeting rheumatoid scleroderma
